Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy.

William F Baker1

  • 1Center for Health Sciences, UCLA, USA. wbaker@thrombosiscenter.com

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|January 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Destructive Giant Cell Tumor of the Capitate: A Unique Case of Carpal Reconstruction.

Hand (New York, N.Y.)·2026
Same author

An Isolated Midsubstance ACL Tear Repaired With the BEAR System.

Video journal of sports medicine·2025
Same author

Tramadol-based multimodal pain protocols after arthroscopic rotator cuff repair are similarly effective as oxycodone-based protocols with fewer morphine milligram equivalents prescribed and lower risk of refills.

Journal of orthopaedics·2025
Same author

Does central sensitization correlate with two-year postoperative functional outcome scores following hip arthroscopy?

Journal of orthopaedics·2023
Same author

Use of Telemedicine Among Hand Surgeons and Their Patients.

The Journal of hand surgery·2023
Same author

Stability of trusses by graphic statics.

Royal Society open science·2021
Same journal

Risk Prediction Models for Deep Vein Thrombosis in Patients With Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same journal

Efficacy of an Integrated Nursing Protocol for the Management of Postoperative Upper Limb Circulatory Complications Following Transradial Coronary Intervention.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same journal

Dual-Channel Inhibition With Rivaroxaban and Aspirin for Thromboprophylaxis in Patients With Long-Term Inferior Vena Cava Filter Implantation: A Two-Center Cohort Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same journal

Association Between TNF-Alpha Levels and Atrial Fibrillation Outcomes: A Systematic Review and Meta-Analysis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same journal

Interpretation of Prothrombin Time and Activated Partial Thromboplastin Time Mixing Studies Using Predefined Algorithms.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same journal

Extensive Inferior Vena Cava Thrombosis in Trauma when IVC Filter Placement Is Not Feasible Managed Using ClotTriever and FlowTriever.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
See all related articles

Thrombolytic agents effectively treat blood clots by increasing plasmin production. Further research aims to develop ideal agents that rapidly open vessels without complications, improving outcomes for thrombosis patients.

Area of Science:

  • Cardiovascular Medicine
  • Hematology

Background:

  • Understanding thrombosis and fibrinolysis is crucial for developing effective treatments.
  • Thrombolytic agents, by increasing plasmin production, show efficacy in arterial and venous thrombotic disorders.

Purpose of the Study:

  • To review the current understanding and therapeutic applications of thrombolytic agents.
  • To define the characteristics of an ideal thrombolytic agent for clinical use.

Main Methods:

  • Review of clinical studies on thrombolytic agents and adjunctive therapies.
  • Analysis of the mechanisms of action and clinical outcomes of plasminogen activators.

Main Results:

  • Thrombolytic therapy demonstrates significant efficacy in treating thrombotic disorders.

Related Experiment Videos

  • Adjunctive therapies, including angioplasty and stenting, enhance thrombolysis benefits.
  • Newer agents and protocols show promise for improved patient survival.

    • Conclusions:

    • Thrombolytic agents are vital in managing thrombosis, with ongoing advancements promising better outcomes.
    • The ideal thrombolytic agent would rapidly restore blood flow without adverse effects like hemorrhage or reocclusion.